As of September 2026 Rapport Therapeutics has a market cap of A$2.72 Billion. This makes Rapport Therapeutics the world's 5046th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Sep 17th, 2026 the market cap of Rapport Therapeutics was reported to be: